Michel Velez

Michel Velez

Oncology
8375 Northwest 53rd Terrace
Doral, FL 33166

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients.

Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2024

EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations.

EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations.

Journal: Clinical lung cancer
Published: January 08, 2021

Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer.

Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer.

Journal: Hematology/oncology and stem cell therapy
Published: January 11, 2017

Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.

Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: February 01, 2015

Overcoming the resistance to crizotinib in patients with non-small cell lung cancer harboring EML4/ALK translocation.

Overcoming the resistance to crizotinib in patients with non-small cell lung cancer harboring EML4/ALK translocation.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 20, 2013

New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies.

New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies.

Journal: Future oncology (London, England)
Published: May 08, 2013

Emerging role of multikinase inhibitors for refractory thyroid cancer.

Emerging role of multikinase inhibitors for refractory thyroid cancer.

Journal: Biologics : targets & therapy
Published: August 21, 2012

Safety and efficacy of pemetrexed in maintenance therapy of non-small cell lung cancer.

Safety and efficacy of pemetrexed in maintenance therapy of non-small cell lung cancer.

Journal: Clinical Medicine Insights. Oncology
Published: March 14, 2012

Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC.

Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC.

Journal: Expert review of anticancer therapy
Published: April 20, 2010
Showing 1-9 of 9

Last Updated: 09/26/2026